期刊文献+

冠状病毒3Cpro蛋白酶抑制剂GC376的合成研究

Synthesis of coronavirus 3Cpro protease inhibitor GC376
下载PDF
导出
摘要 GC376是一种广谱性冠状病毒3Cpro蛋白酶抑制剂。本文以N-Boc-L-谷氨酸二甲酯作为起始原料,经氰化、环化、去Boc、酰胺化、还原、氧化、磺酸盐化合成了GC376,中间体及目标化合物的结构经~1H NMR表征。设计了两条合成路线,路线2较路线1减少了两步反应,提高了反应收率。采用单因素法,考察了还原剂种类,底物的浓度和还原剂PtO的载样量对关键中间体3的合成条件的影响,将3的合成收率由文献报道的58%提高到83%;HOAt作为缩合剂,使中间体5的收率由文献报道的72%提高到82%。本文对于GC376的合成研究具有重要的实际应用价值。 GC376 is a broad-spectrum coronavirus 3 Cpro protease inhibitor.In this paper,GC376 was synthesized from N-Boc-L-glutamic dimethyl ester by cyanidation,cyclization,de-Boc,amidation,reduction,oxidation and sulfonation,and the structures of the intermediate and the target compound were characterized by~1H NMR.This paper designed two synthesis routes which route 2 reduced two reaction steps and improved the reaction yield than route 1.The single factor method was used to investigate the effects of the type of reducing agent,the concentration of the substrate and the loading amount of reducing agent PtOon the synthesis conditions of the key intermediate 3.The synthesis yield of 3 was increased from 58%reported in the literature to 83%.As a condensation agent,HOAt increased the yield of intermediate 5 from 72%to 82%.This paper had important practical application value for the synthesis research of GC376.
作者 刘海彬 刘永祥 林敬生 LIU Hai-bin;LIU Yong-xiang;LIN Jing-sheng(School of Biomedical and Chemical Engineering,Liaoning Institute of Science and Technology,Benxi 117004,China;Wuya College of Innovation,Shenyang Pharmaceutical University,Benxi 117004,China)
出处 《化学研究与应用》 CAS CSCD 北大核心 2022年第9期2135-2141,共7页 Chemical Research and Application
基金 国家自然科学基金面上项目(21977073)资助。
关键词 冠状病毒 3Cpro蛋白酶抑制剂 GC376 合成 中间体 coronavirus 3Cpro protease inhibitor GC376 Synthesis intermediate
  • 相关文献

参考文献3

二级参考文献35

  • 1丁军,蒋立建,黄斌.合成精胺盐酸盐的新方法[J].现代化工,2004,24(12):35-37. 被引量:1
  • 2高健,许同桃.有机胺及其配合物(第一版)[M].北京:化学工业出版社,2010:169.
  • 3John C. Robinson, Jr. ,H. R. Snydr.β - Phenylethylamine [ J ]. Or- ganic Syntheses, Coll. , 1946,3:720 ; 1995,23:71.
  • 4Gerald Juergen Roth, Biberach, Philipp Lustenberger, et al. Beta- ketoamide compounds with MCH antagonistic activity [ P ]. US 20050245500 (A1).
  • 5Stamos, Dean, Martinborough, Esther, Zimmermann, et al. Heterocy- clic derivatives as modulators of ion channels[ P ]. US: 2009124655 (A1).
  • 6Buchstaller, Hans- Peter, Burgdorf, et al. Isoquinoline Derivatives [ P]. WO: 200582858 (A2) ,2005.
  • 7I. G. Farbenind. Verfaluren zur Darstellungvon - ( 3,4,5 - Trialkoxy- phenyl) - aethylaminen [ P ]. DE526172.
  • 8Kayser, Katherine J. Glenn,et al. Bioorganic & Medicinal Chemistry Letters, 2007, 17 (7) :2068 - 2073.
  • 9Wiles, Jason A. , Wang, Qiuping, Lucien, et al. Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7 - position: Synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells[ J ]. Bioorganic and Medici- nal Chemistry Letters, 2006,16 : 1272 - 1276.
  • 10LASZLO HEGEDUS, TIBOR MATHE. Selective heterogeneous catalyt- ic hydrogenation of nitriles to primary ines in liquid phase Partl Hydro- genation of benzion trile over palladium. [ J ]. Applcata A, 2005 : 296 : 209 - 215.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部